C. Helwick

Sorafenib Improves Survival in Hepatocellular Carcinoma: Results of a Phase 3 Randomized, Placebo-Controlled Trial

J. Llovet, C. Helwick, 2007 .

Final Results of the EORTC Intergroup Randomized Phase 3 Study 40983 Evaluating the Benefit of Perioperative FOLFOX4 Chemotherapy for Patients with Potentially Resectable Colorectal Cancer Liver Metastases

C. Helwick, N. Nordlinger, 2007 .

Therapeutic Leap for Multiple Myeloma in 2015: Unprecedented FDA Drug Approvals.

C. Helwick, 2016, American health & drug benefits.